Perspectives of Radiation Therapy in Norway Stener Kvinnsland MD, PhD CEO, Haukeland University Hospital.

Slides:



Advertisements
Similar presentations
Inflammatory Bowel Disease: Overview
Advertisements

PSA in 2010 James L. Mohler, MD Chair, NCCN Prostate Cancer Panel Department of Urology Prostate Cancer Research Program Roswell Park Cancer Institute,
Radiation therapy for Early Stage Prostate Cancer John A. Kalapurakal MD Professor, Radiation Oncology Northwestern University Medical School Chicago,
CirculatingTumor Cells: Toward a clinical benefit? Giuseppe Naso MD, PhD, Associated Professor of Medical Oncology Director of Traslational Oncology Paola.
Accountability and Improvement: Lessons from the Field 2007 National Health PolicyConference Christopher Queram President and CEO.
1 s Share 2 s Share 3 s Share settles with 1 for $200,000 (the limit of 1 s insurance policy) settles with 1 for $700,000 Fault allocation: =0%, 1 =50%,
Thoracic surgery in Norway 2010 Norwegian Association for Cardiothoracic Surgery Norwegian register for general thoracic surgery. Steinar Solberg, MD,
Galactosemia By Nate and Dj. What is Galactosemia? Galactose in the blood Galactose in the blood This is found mainly in dairy products This is found.
It’s always…. DUCK SEASON Here at… NSU Joe Evans Veteran Agent (954) Direct Line and.
Excellent healthcare – locally delivered How far away are we from 20 million on ART by 2020? Meg Doherty, MD, MPH, PhD Coordinator Treatment and Care WHO.
Breast Cancer Conference 8 October 2013 Sheffield Breast Services.
Powerpoint Jeopardy Category 1Category 2Category 3Category 4Category
GLOBAL POSITIONING SYSTEM
Surgery – Quality of Life Panel Discussion Jan Olofsson, MD, PhD Professor & Head Department of Otolaryngology/ Head & Neck Surgery Haukeland University.
Surgery v Radiation in Prostate Cancer Prasanna Sooriakumaran MD PhD & Peter Wiklund MD PhD.
NRI (Nordic Health Research and Innovation Networks) Stener Kvinnsland CEO Haukeland University Hospital.
DEBBIE A. MCKNIGHT.  Member of the radiology ONCOLOGY team  Plan and calculating the ionizing radiation doses for tumor localization  Works under the.
NCDB Report on Breast Cancer at Sibley Cancer Committee Feb Cancer Liaison Physician Karen Lisa Smith MD MPH.
Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.
Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.
Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer  Thomas J. Pugh, MD, Mark F.
Ulcerative Colitis (UC)-Associated Colorectal Cancer (CRC) Patients Who Receives Colorectal Surgery More Likely Receive Blood Transfusion Than Crohn’s.
Copyright © 2012 American Medical Association. All rights reserved.
Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate.
A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute  Thomas J. FitzGerald,
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast.
Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Weight Gain and its Correlates among Breast Cancer Survivors
بسم الله الرحمن الرحیم حوادث پرتویی در پزشکی
سرطان الثدي Breast Cancer
Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B- cell lymphomas: A retrospective study  Amrita Goyal, MD, Joi B.
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,
Is the Rate of Pneumonectomy Higher in Right Middle Lobe Lung Cancer Than in Other Right-Sided Locations?  Caroline Rivera, MD, Pierre Mordant, MD, PhD,
Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy  Barbara.
The Role of Radiation Therapy in Malignant Thymoma: A Surveillance, Epidemiology, and End Results Database Analysis  Annemarie T. Fernandes, BA, Eric.
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base  Amy C. Moreno,
Acupressure Bands Are Effective in Reducing Radiation Therapy-Related Nausea  Joseph A. Roscoe, PhD, Peter Bushunow, MD, Pascal Jean-Pierre, PhD, Charles.
Cooperative Group Clinical Trials in General Thoracic Surgery: Report From the 2012 Robert Ginsberg Clinical Trials Meeting of the General Thoracic Surgical.
The Symptom Experience in Rectal Cancer Survivors
Adil Ayub, MD, Sadiq S. Rehmani, MD, Adnan M
The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer  Justin F. Gainor, MD, Sai-Hong Ignatius Ou, MD, PhD, Jennifer.
Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent.
Photodynamic Therapy for Early Stage Central Type of Lung Cancer
Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD 
Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection  Shalini Garg, MD,
Patterns of Cardiac Perfusion Abnormalities After Chemoradiotherapy in Patients with Lung Cancer  Isis W. Gayed, MD, H Helen Liu, PhD, Xiong Wei, MD,
Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy  Todd.
Steven Z. Pantilat, MD, Kathleen M. Kerr, BA, J
Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center 
A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596):
Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma  Liru He, MD, Pamela K. Allen, PhD, Adam.
Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis  William A. Stokes, MD, Brian.
Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed  Emanuela Taioli, MD, PhD, Raja Flores, MD 
Álvaro Sanz Rubiales, MD, PhD, Virginia de la Cruz, MD 
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey  Daniel Morgensztern, MD, Shean Huey Ng,
Long-Term Results of a Phase II Trial of Induction Paclitaxel-Carboplatin Followed by Concurrent Radiation Therapy and Weekly Paclitaxel and Consolidation.
Pain Response Rates After Conventional Radiation Therapy for Bone Metastases in Prospective Nonrandomized Studies: A Systematic Review  Tetsuo Saito,
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Our Community Where is …?.
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Roger Hakimian, MD, Hongbin Fang, PhD, Leno Thomas, MD, Martin J
Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018  Thomas M. Pisansky, MD, Ian M. Thompson,
Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Public health impact of colonoscopy use on colorectal cancer mortality in Germany and the United States  Chen Chen, MSPH, Christian Stock, PhD, Michael.
Long-Term Follow-Up of a Phase I/II Trial of Dose Escalating Three-Dimensional Conformal Thoracic Radiation Therapy with Induction and Concurrent Carboplatin.
Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node- negative T3 and T4 non–small cell lung cancer  Benedict D.T. Daly, MD,
Presentation transcript:

Perspectives of Radiation Therapy in Norway Stener Kvinnsland MD, PhD CEO, Haukeland University Hospital

Radiation Therapy in Norway Cancer Statistics – new cases/y >50 y: 87% <24 y: 1.4% – deaths/y –5y relative survival (2005-9) m/f: 65.9%/68.2%

Demography and Epidemiology

Stener Kvinnsland Avdelingsleder, professor dr. med Onkologisk avdeling, Haukeland sykehus

Cancer Biology and Therapy Genetic disease Invasion and metastasis Natural course and choice of therapy –Surgery (contribution to survival: 40%) –Radiation therapy (10-15%) –Medical therapy (10-15%) Therapeutic ratio

Radiation therapy Estimated need of radiotherapy: 50-60% OF ALL PATIENTS

Indications, and number of patients Main indication: –Radiation therapy with a curative intention in children and young adults Estimates of patient numbers: –100 (very restricted use) –1000 (wider indications)

Thank you for your attention!!